7-(tert-Butyl)-5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidin-4(3H)-one

Catalog No.: 
ACENYA914
CAS No.: 
380902-66-9
Molecular Formula: 
C14H18N2OS
Molecular Weight: 
262.38
7-(tert-Butyl)-5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidin-4(3H)-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%
5g95%

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name7-(tert-Butyl)-5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidin-4(3H)-one
IUPAC Name7-(tert-butyl)-5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidin-4(3H)-one
MDL No.MFCD02995063
Molecular FormulaC14H18N2OS
Molecular Weight262.38
SMILESO=C1C(C2=C(CC(C(C)(C)C)CC2)S3)=C3N=CN1
InChI KeyWLYBCFOZMCEZFA-UHFFFAOYSA-N
SynonymOTAVA-BB BB7014320659;AURORA 21415;7-TERT-BUTYL-5,6,7,8-TETRAHYDRO-3H-BENZO[4,5]THIENO[2,3-D]PYRIMIDIN-4-ONE;AKOS 92202;7-(Tert-butyl)-5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidin-4-ol
CAS No.380902-66-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACENYA914 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACENYA914 route product structure diagram
    ACENYA914380902-66-9
Inquiry

2. ACENYA914 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACENYA914 route product structure diagram
    ACENYA914380902-66-9
Inquiry

3. ACENYA914 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACENYA914 route product structure diagram
    ACENYA914380902-66-9
Inquiry

Comments (0)